SPOTLIGHT: Aussie docs ask pharma to fund staff

Staffing shortfalls at Sydney's Liverpool Hospital are so acute that senior doctors have been lobbying pharma companies for funds to recruit workers; one neurosurgeon asked an unnamed drug maker for $20,000 to pay for an administrative assistant, saying the practice was "widespread." Report

Suggested Articles

Despite having lost some of its novelty, AZ's Brilinta is touting bleeding data over aspirin that could be a big break in acute coronary syndrome.

More than a year after J&J and Bayer pulled the plug on Xarelto in patients after a rare valve replacement, the pair are still seeking answers.

Having already whiffed on one crucial heart failure trial, Novartis is focusing on "profound" data from its Entresto studies in hopes for another go.